292 related articles for article (PubMed ID: 31367619)
1. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma.
Luo SH; Chu JG; Huang H; Yao KC
World J Clin Cases; 2019 Jul; 7(13):1599-1610. PubMed ID: 31367619
[TBL] [Abstract][Full Text] [Related]
2. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
3. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt.
Lu HL; Xuan FF; Luo YC; Qin X
Abdom Radiol (NY); 2021 Nov; 46(11):5417-5427. PubMed ID: 34302511
[TBL] [Abstract][Full Text] [Related]
5. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
Wei J; Li H; Li C
J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
[TBL] [Abstract][Full Text] [Related]
6. Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency.
Dong F; Luo SH; Zheng LJ; Chu JG; Huang H; Zhang XQ; Yao KC
World J Clin Cases; 2019 Sep; 7(17):2450-2462. PubMed ID: 31559281
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis.
Liu L; Zhao Y; Qi X; Cai G; He C; Guo W; Yin Z; Chen H; Chen X; Fan D; Han G
Hepatol Res; 2014 Jun; 44(6):621-30. PubMed ID: 23679937
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review.
Norero B; Bosch J; Berzigotti A; Rodrigues SG
United European Gastroenterol J; 2023 Oct; 11(8):733-744. PubMed ID: 37736854
[TBL] [Abstract][Full Text] [Related]
10. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma.
Balducci D; Montori M; De Blasio F; Di Bucchianico A; Argenziano ME; Baroni GS; Scarpellini E
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374354
[TBL] [Abstract][Full Text] [Related]
11. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Qiu B; Li K; Dong X; Liu FQ
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
[TBL] [Abstract][Full Text] [Related]
12. Where does TIPS fit in the management of patients with cirrhosis?
García-Pagán JC; Saffo S; Mandorfer M; Garcia-Tsao G
JHEP Rep; 2020 Aug; 2(4):100122. PubMed ID: 32671331
[TBL] [Abstract][Full Text] [Related]
13. Prognosis after splenectomy plus pericardial devascularization
Qi WL; Wen J; Wen TF; Peng W; Zhang XY; Shen JY; Li X; Li C
World J Gastrointest Surg; 2023 Aug; 15(8):1641-1651. PubMed ID: 37701695
[TBL] [Abstract][Full Text] [Related]
14. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt.
Luo SH; Chu JG; Huang H; Yao KC
World J Gastroenterol; 2017 Jul; 23(26):4779-4787. PubMed ID: 28765699
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
16. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
Qiu Z; Wang G; Yan H; Qi H; Zuo M; Wang G; Jiang W; Chen Z; Xue J; Lu L; Zhang F; Gao F
Eur Radiol; 2022 Oct; 32(10):6777-6787. PubMed ID: 35441840
[TBL] [Abstract][Full Text] [Related]
17. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
18. Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension.
Xie Y; Lyu T; Song L; Tong X; Wang J; Zou Y
J Clin Exp Hepatol; 2024; 14(2):101305. PubMed ID: 38130294
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary application of transjugular intrahepatic portosystemic shunt in individualized treatment of patients with cirrhotic portal hypertension complicated with refractory ascites and variceal hemorrhage].
Jiang MM; Xu H; Zhang QQ; Wei N; Xu W; Cui YF; Liu HT; Zu MH; Wang WL; Gao ZK
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(47):3737-3740. PubMed ID: 31874500
[No Abstract] [Full Text] [Related]
20. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
